Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic study helps patients with pancreatic cancer experience significantly less pain

03.03.2004


The intense pain many patients with pancreatic cancer experience may be reduced by more than 50 percent using a nerve block technique along with the standard pain-relieving medications. That is the finding of a Mayo Clinic study that will be published in the March 3 edition of the Journal of the American Medical Association (JAMA).



The study also found that the neurolytic celiac plexus block (NCPB), the type of nerve block used, continued to provide sustained pain relief over several months. This benefit may allow some patients with advanced pancreatic cancer to live more comfortably for the duration of their lives.

The Mayo Clinic study is the largest research study to date on managing pain in patients with pancreatic cancer, using the NCPB technique along with pain-relieving medications compared to pain-relieving medications alone. The study was led by Gilbert Wong, M.D., a Mayo Clinic anesthesiologist specializing in pain medicine, who also heads the Mayo Clinic Cancer Center’s Psychosocial Oncology Group.


"The pain caused by pancreatic cancer ranks among the most horrible pains anyone can experience or imagine," says Dr. Wong. "Previous research studies have suggested that 85 percent of patients with advanced disease can experience significant pain."

Pancreatic cancer is an aggressive tumor associated with a high mortality. This year an estimated 31,000 people in the United States will be diagnosed with pancreatic cancer and the majority of them will die within a year.

The Mayo Clinic study involved 100 patients who had advanced pancreatic cancer that could not be surgically removed, and were experiencing significant pain. The patients were randomly assigned to receive either the NCPB or potent pain-relieving medications alone, such as morphine, which is typical treatment for cancer pain. Subsequently, all patients could receive additional pain-relieving medications as needed. All of the patients were followed until death or for at least one year after enrolling in the study.

"Pain-relieving medications alone provided the patients with a 27 percent reduction in pain," Dr. Wong says. "Our goal was to find a better way to further reduce the pain and thereby help them live their remaining time more comfortably.

"We found that patients who also received the NCPB reported a greater than 50 percent reduction in their pain, almost twice the relief that patients who received only the pain-relieving medications got," says Dr. Wong. "Equally as important, we found that the pain relief from the combination of nerve block and pain-relieving medications lasted longer, helping some patients for the duration of their illness."

Pancreatic cancer often shows no warning signs until the tumor has grown to the point that it cannot be surgically removed. Then, approximately 80 percent of patients begin to have significant pain in the upper abdomen and mid-back. By that time, however, the cancer is often advanced and the average survival time is about six months.

"The findings of our study suggest the nerve block technique works for a substantial number of patients with advanced pancreatic cancer and should be considered as a treatment option," says Dr. Wong. "It’s an important benefit to patients with pancreatic cancer and important information for physicians who take care of them."

Study Details

One hundred patients with nonresectable pancreatic cancer and experiencing significant pain were enrolled between October 1997 and January 2001 and followed until demise or at least one year. Baseline pain was similar among patients assigned to receive the NCPB and those receiving systemic analgesic therapy (SAT) alone.

In the first week of treatment, patients in both groups reported less intense pain and improved quality of life, but patients receiving the NCPB had a larger decrease in pain than patients receiving SAT. At six weeks, fewer patients receiving the NCPB reported moderate or severe pain compared to SAT patients. Repeated analysis through the first six months after enrolling in the study showed NCPB patients had significantly lower pain over time than SAT patients. However, consumption of opioids and frequency of opioid side effects, such as sleepiness, nausea and constipation, were not significantly different between the two groups.

One year after enrolling in the study, 16 percent of patients receiving the NCPB and six percent of SAT patients were still alive.


The Mayo Clinic study, titled "Effects of Neurolytic Celiac Plexus Block on Pain Relief, Quality of Life and Survival in Patients with Unresectable Pancreatic Cancer," was funded with grants from FAER -- Foundation for Anesthesia, Education and Research, Cancer Treatment Research Foundation, and the Ehlers Family for Psychosocial Oncology and Spiritual Care Research at the Mayo Clinic Cancer Center.

To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories

Mary Lawson | EurekAlert!
Further information:
http://www.mayoclinic.org/news
http://www.mayoclinic.com

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>